Jun 11 |
Ono Pharmaceutical completes tender offer for Deciphera
|
Jun 3 |
Deciphera Pharmaceuticals Announces Oral Presentation of Results from MOTION Pivotal Phase 3 Study of Vimseltinib in Patients with Tenosynovial Giant Cell Tumor (TGCT) at the 2024 ASCO Annual Meeting and Online Publication in The Lancet
|
May 22 |
Deciphera Pharmaceuticals ticks higher as HSR waiting period for ONO sale expires
|
May 10 |
Here's What Key Metrics Tell Us About Deciphera Pharmaceuticals (DCPH) Q1 Earnings
|
May 10 |
Deciphera Pharmaceuticals, Inc. (DCPH) Reports Q1 Loss, Misses Revenue Estimates
|
May 5 |
Wall Street Breakfast: The Week Ahead
|
May 3 |
The Zacks Analyst Blog Highlights Gilead Sciences, GSK, Deciphera, Bristol Myers and Editas Medicine
|
May 2 |
Biotech Stock Roundup: GILD's GSK' Q1 Earnings, DCPH Soars on Acquisition News & More
|
Apr 30 |
ONO to acquire Deciphera Pharmaceuticals in $2.4B deal
|
Apr 30 |
Japan's Ono Pharma says $2.4 bln Deciphera purchase 'first step' for global expansion
|